aTYR PHARMA INC — Form D
aTYR PHARMA INC of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-09-15. The offering totals $45.8M, of which $45.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-09-15
- Form: D
- Accession: 0001339970-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $45.8M
- Amount sold: $45.8M
- Investors: 11
- Date of first sale: 2017-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-294795
Issuer
- Name: aTYR PHARMA INC
- CIK: 0001339970
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3545 JOHN HOPKINS COURT, STE #250, SAN DIEGO, CA, 92121
- Phone: 858-731-8389
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Srini S Akkaraju | Director | San Diego, CA |
| JAMES C BLAIR | Director | WOBURN, MA |
| John K Clarke | Director | Walla Walla, WA |
| Timothy P Coughlin | Director | San Diego, CA |
| Mark P Goldberg | Director | San Diego, CA |
| Jeffrey S Hatfield | Director | Boulder, CO |
| John D Mendlein | Director | San Diego, CA |
| Amir H Nashat, Sc.D. | Director | San Diego, CA |
| Paul K Schimmel | Director | San Diego, CA |
| John T Blake | Executive Officer | SYLMAR, CA |
| Nancy D Krueger | Executive Officer | San Diego, CA |
| John D Mendlein | Executive Officer | San Diego, CA |
| Sanuj K Ravindran | Executive Officer | San Diego, CA |
| Sanjay S Shukla | Executive Officer | San Diego, CA |
| Amir C Nashat | Director | San Diego, CA |
| Paul C Schimmel | Director | San Diego, CA |
| Akkaraju C Srinivas | Director | San Diego, CA |
| David C Weiner | Executive Officer | San Diego, CA |
| Ed C Penhoet | Director | San Diego, CA |
| Frederic C Chereau | Executive Officer | San Diego, CA |
| Kathryn C Falberg | Director | San Diego, CA |
Other filings by this issuer (1)
More